Home / Topics / biopharmaceuticals

biopharmaceuticals Podcasts

7 episodes about biopharmaceuticals

Insmed Incorporated Announced Q1 2026 Earnings on May 7, 2026, Reporting "in the first 2 full quarters, we've done $350 million of revenue". artwork

Insmed Incorporated Announced Q1 2026 Earnings on May 7, 2026, Reporting "in the first 2 full quarters, we've done $350 million of revenue".
Insmed Incorporated (INSM)
• 11:54 •Ep 159 •The Earnings Debate •▶ Play on Apple
Rhythm Pharmaceuticals, Inc. (RYTM) Announced Q1 2026 Earnings on May 5, 2026, Reporting "Revenues for the quarter were $60 million." artwork

Rhythm Pharmaceuticals, Inc. (RYTM) Announced Q1 2026 Earnings on May 5, 2026, Reporting "Revenues for the quarter were $60 million."
Rhythm Pharmaceuticals Inc. (RYTM)
• 17:56 •Ep 146 •The Earnings Debate •▶ Play on Apple
Amgen Inc. (AMGN) Announced Q1 2026 Earnings on April 30, 2026, Reporting "4% growth in product sales" artwork

Amgen Inc. (AMGN) Announced Q1 2026 Earnings on April 30, 2026, Reporting "4% growth in product sales"
Amgen Inc. (AMGN)
• 22:12 •Ep 123 •The Earnings Debate •▶ Play on Apple
Inside Gilead Sciences: Leading in virology while diversifying into oncology and inflammation artwork

Inside Gilead Sciences: Leading in virology while diversifying into oncology and inflammation
Gilead Sciences Inc. (GILD)
• 48:38 •Ep 17 •Inside the Business •▶ Play on Apple
Gilead Sciences Tech Radar: Acquiring in vivo cell therapy platforms to reduce costs artwork

Gilead Sciences Tech Radar: Acquiring in vivo cell therapy platforms to reduce costs
Gilead Sciences Inc. (GILD)
• 18:51 •Ep 14 •Business Tech Radar •▶ Play on Apple
Inside Amgen: A biologics leader driving volume growth through cardiometabolic and rare disease innovation artwork

Inside Amgen: A biologics leader driving volume growth through cardiometabolic and rare disease innovation
Amgen (AMGN)
• 29:06 •Ep 13 •Inside the Business •▶ Play on Apple
Amgen Tech Radar: Amgen is deploying artificial intelligence to accelerate therapeutic discovery artwork

Amgen Tech Radar: Amgen is deploying artificial intelligence to accelerate therapeutic discovery
Amgen (AMGN)
• 20:22 •Ep 10 •Business Tech Radar •▶ Play on Apple